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Stem cell research has the potential to substantially improve medical care. The
prospective clinical use of adult mesenchymal stem cells holds enormous promise for
improved treatment of a large number of diseases in humans and companion animals.
Although the use of bone-marrow-derived mesenchymal stem cells appears to be a
popular therapy; the therapy suffers from the donor-to-donor variation in the quality and
quantity of harvested cells. This observation has been reported in humans, mice, dogs,
and recently from our laboratory in horses. One critical biological factor that
researchers and clinicians must take into account is this variability and how it may affect
the clinical outcome in regenerative therapy. The focus of research in the Laboratory of
Regenerative Medicine at the College of Veterinary Medicine is to understand this
variation in large animals. Our research is focused on the study of equine
mesenchymal stem cell biology prior to its use in the clinic. We have optimized in vitro
molecular and cellular assays to isolate, characterize, and differentiate horse and goat
adult mesenchymal stem cells; we can generate ex vivo and in vivo models of specific
diseases; wounds, cartilage and tendon lesions, cortical and orthotropic bone defects to
test their biological function in regeneration. Additionally, we are collaborating with the
Nanotechnology Center (Arkansas) and a couple of private companies to assess the
behavior of adult mesenchymal stem cells towards novel biomaterials or scaffolds
generated for the treatment of musculoskeletal injuries. The goal of this three-step
process is to improve clinical outcomes as well as increase our basic knowledge of
stem cell function. With the progress made in the last 4 years, we are the only research
laboratory in Tennessee to provide and use off-the-shelf equine allogenic mesenchymal
stem cell stocks for immediate administration into clinical cases.

